Results 231 to 240 of about 10,900 (261)

Controversies in Palivizumab Use

The Pediatric Infectious Disease Journal, 2004
Timothy P, Stevens, Caroline B, Hall
openaire   +2 more sources

Palivizumab/ribavirin

Reactions Weekly, 2023
openaire   +1 more source

Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry

Journal of Perinatology, 2008
Marnie L Boron
exaly  

Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants

Human Vaccines and Immunotherapeutics, 2014
Michael L Forbes, Christopher S Ambrose
exaly  

Adherence and outcomes: a systematic review of palivizumab utilization

Expert Review of Respiratory Medicine, 2018
Abby Li, Krista L Lanctôt, Bosco A Paes
exaly  

Palivizumab

Reactions Weekly, 2010
openaire   +1 more source

PALIVIZUMAB (SYNAGIS)

American Journal of Nursing, 1999
openaire   +1 more source

Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants

Infectious Diseases and Therapy, 2017
Robert Clifford, Sally W Wade
exaly  

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

Pediatrics, 2014
Carrie L Byington, Mary Anne Jackson, Shawn Ralston   +2 more
exaly  

The cost effectiveness of palivizumab: a systematic review of the evidence

Journal of Medical Economics, 2010
Kelly Smart, Krista L Lanctôt, Bosco A Paes   +2 more
exaly